Avalo Therapeutics, Inc. ($AVTX)
Sullivan Christopher Ryan โ Chief Financial Officer
Shares
47,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Sullivan Christopher Ryan |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | May 6, 2026 |
| Expiration Date | Jan 28, 2035 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | May 7, 2026 |
| Shares Purchased | 47,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 116,000 |
| Derivative | Derivative |
| Accession Number | 0001810417-26-000010 |
| Document | View SEC Filing |